MERSI Trained International Fellows. MERSI, Top Ophthalmology Practice in Boston, Massachusetts.

Fellowship Program Requirements

Massachusetts Eye Research and Surgery Institution (MERSI) offers unique opportunities for education, training, and research in the field of ocular inflammatory diseases. These programs are in partnership with the Ocular Immunology and Uveitis Foundation (OIUF).

Please note: The MERSI/OIUF Fellowship Program is not affiliated with a hospital or university. As such, the program cannot sponsor visas for international visitors. All internationally trained applicants must arrange visas and unlimited medical licenses from the Commonwealth of Massachusetts (if applicable) on their own prior to applying.

MERSI/OIUF Fellowship Program Opportunities

Clinical Fellowship
The OIUF Clinical Fellowship program is offered to those who have completed an Ophthalmology residency and have (or can obtain) an unlimited license to practice medicine in the Commonwealth of Massachusetts. This program is compliant with the Association of University Professors of Ophthalmology (AUPO FCC compliant). Each fellowship is a year-long position.

How to Apply:

  • Please review OIUF’s Ocular Immunology Fellowship Overview (See below)
  • Register and apply through the SF Ophthalmology Fellowship match in advance of the
    stated deadline. Visit this link for more information.

 

Research Fellowships

  1. Research Fellowship
  2. Pre-Residency Research

 

Fellowship Research and Pre-Residency Fellowship positions do not require a license to practice medicine. Fellows will see patients daily under the supervision of licensed clinical preceptors but may not independently perform medical procedures, surgeries, or other activities restricted to licensed physicians, in accordance with state law. An emphasis on clinical research will be incorporated into this program.

How to Apply:

  • Please review OIUF’s Ocular Immunology Fellowship Overview (See below)
  • Please send an email indicating your interest to Scott Evans (sevans@mersi.com) with the following items…
    • Cover letter
    • CV 
    • Personal statement
    • Proof of educational accomplishments
    • Letters of recommendation
  • You will be notified whether MERSI/OIUF is extending an invitation to interview for a Fellowship position. Unless otherwise indicated, interviews will be conducted virtually. On-site interviews or visits to the clinic can be arranged upon request if you wish. For any additional information with regard to OIUF’s Ocular Immunology Fellowship Program at MERSI, please contact: Scott Evans (sevans@mersi.com).

 

For any additional information with regard to OIUF’s Ocular Immunology Fellowship Program at MERSI, please contact: Scott Evans (sevans@mersi.com).

Ocular Immunology Fellowship Program Overview

Our major goal is to provide a resource for individuals who are determined to become the best that they’re capable of becoming: from a personal, character point of view, as well as from a physician/clinician/caretaker point of view, and from a restless, question-asking, scientist point of view.

The level to which we succeed in our goal is mirrored by the behaviors of the individuals completing the Fellowship training program: behaviors both from a character/social perspective and from a clinician/scientist perspective. We have reason, so far, to believe that the program accomplishes its goal. Some Fellows take more with them from this environment than do others. All, however, have selflessly recognized the quid pro quo for the benefits they derive from the program: 100% dedicated effort to the Fellowship training program while in it, total commitment to the patients for whom they are responsible, and absolute honesty and scientific integrity.

C. Stephen Foster, MD, FACS, FACR, Founder of MERSI and OIUF

Educational Goals
The primary goals of the OIUF Fellowship at MERSI are to develop diagnostic and therapeutic skills in caring for patients with destructive ocular diseases mediated by abnormal autoimmune or infectious processes, as well as an enhanced understanding of general ophthalmic disease, and to develop an information base in basic ocular immunology, with associated research skills, to facilitate appropriate total care of patients with ocular inflammation and any associated secondary comorbidities. Fellows are expected to utilize their growing understanding to formulate and lead their own research projects to be submitted for publication throughout the year.

Basic Objectives
Differential diagnosis, evaluation for formulation of diagnostic strategy, and management of the following diseases and associated co-morbidities:

  1. Cicatricial pemphigoid and other forms of chronic cicatrizing conjunctivitis
  2. Peripheral ulcerative keratitis
  3. Scleritis
  4. Uveitis
  5. Retinal vasculitis
  6. Orbital Inflammation
  7. Cystoid macular edema

 

Familiarity with the following clinical skills will be gained/assessed:

  1. Pertinent yet detailed formation of history/review of systems, assessment, and plan
  2. Measurement of visual acuity
  3. Measurement of intraocular pressure via tonometry
  4. Slit lamp examination (including SUN and IUSG criteria for inflammation)
  5. Dilated fundus examination, including slit lamp biomicroscopy and indirect ophthalmoscopy with retina drawing
  6. External photography and interpretation of diagnostic testing, including but not limited to
    optical coherence tomography (OCT), fluorescein angiography (FA), and visual field (VF)
  7. Interpretation of monitoring blood work and serologies
  8. Laboratory evaluation of conjunctival/scleral specimens
  9. Formulation of monitoring and treatment plans for patients with ocular inflammatory diseases

 

Additionally, fellows will gain ample experience in conditions of general ophthalmology, including medical and surgical interventions, and how these can be managed in patients with ocular inflammatory disease. This consists of conditions such as dry eye, glaucoma, cataracts, retinopathy, medical and surgical retina, in patients with OID or otherwise, etc. Additionally, it is to be emphasized that the proper, safe use of cytotoxic and biologic drugs requires significant medical training and experience, and significant, frequent, longitudinal experience in the use of such agents, recognition of complications induced by these agents, and management of such complications.

Our teaching emphasizes the case method approach in which each patient is to be examined initially by the Fellow and then formally presented to the attending staff member for discussion of diagnosis and treatment. Clinical work will be the primary source of education for this fellowship. Additional readings and pertinent references from suggested readings will often supplement clinical experiences. Used properly, this will provide the opportunity for recognition and diagnosis of disease and will be the stimulus for in-depth reading about each disease entity.

Clinical Activities

Fellowship training will take place at MERSI in Waltham, MA. This comprehensive outpatient clinic provides tertiary care not only for uveitis and OID but also for many subspecialties of Ophthalmology, including dry eye, cataracts, glaucoma, and medical and surgical retina. MERSI houses a blood lab, a pathology lab, an infusion suite, and minor procedure and laser rooms, and is conveniently located above an outpatient surgery center where our surgeons practice. The clinic is in operation Monday through Friday as well as on one Saturday per month.

Clinical training will be supplemented by lectures from preceptors and guest speakers, presentations from fellows, and regular laboratory meetings to discuss the progress of individual research projects. Research, presentation, and/or publication of interesting cases or series by fellows is strongly encouraged, especially for Research and Pre-Residency Fellows. We believe that a doctor is a better physician as a result of carefully analyzing a case, reviewing the literature, and reporting the case than by not doing so. We also have the opportunity to present new and/or rare cases to the scientific community and the outcomes associated with our care.